Detailed Information on Publication Record
2023
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling
RAUDENSKÁ, Martina, Jan BALVAN, Klára HÁNĚLOVÁ, Mária BUGAJOVÁ, Michal MASAŘÍK et. al.Basic information
Original name
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling
Authors
RAUDENSKÁ, Martina (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution), Klára HÁNĚLOVÁ (203 Czech Republic, belonging to the institution), Mária BUGAJOVÁ (703 Slovakia, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, AMSTERDAM, ELSEVIER, 2023, 0304-419X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 11.200 in 2022
RIV identification code
RIV/00216224:14110/23:00131127
Organization unit
Faculty of Medicine
UT WoS
001057815400001
Keywords in English
Head and neck cancer; Cancer-associated fibroblasts; Cancer therapy; Tumor microenvironment; Resistance to therapy
Tags
International impact, Reviewed
Změněno: 25/1/2024 14:00, Mgr. Tereza Miškechová
Abstract
V originále
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor-permissive extracellular matrix structure, angiogenesis, or immune and metabolic reprogramming of the tumor microenvironment (TME), with implications for metastasis and resistance to radiotherapy and chemotherapy. The pleiotropic effect of CAFs in TME is likely to reflect the heterogeneity and plasticity of their population, with context-dependent effects on carcinogenesis. The specific properties of CAFs provide many targetable molecules that could play an important role in the future therapy of HNSCC. In this review article, we will focus on the role of CAFs in the TME of HNSCC tumors. We will also discuss clinically relevant agents targeting CAFs, their signals, and signaling pathways, which are activated by CAFs in cancer cells, with the potential for repurposing for HNSCC therapy.
Links
GA21-06873S, research and development project |
| ||
MUNI/A/1343/2022, interní kód MU |
| ||
MUNI/A/1370/2022, interní kód MU |
| ||
NU22-03-00202, research and development project |
|